Pharmacokinetics of intravenous anaesthetics: implications for clinical use.
D000530:Alfaxalone Alfadolone Mixture / Q000378:metabolism; D000771:Anesthesia, Intravenous; D000777:Anesthetics / Q000378:metabolism*; D000818:Animals; D001711:Biotransformation; D003975:Diazepam / Q000378:metabolism; D004329:Droperidol / Q000378:metabolism; D004347:Drug Interactions; D005045:Etomidate / Q000378:metabolism; D005260:Female; D005283:Fentanyl / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007649:Ketamine / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism; D008431:Maternal-Fetal Exchange; D008723:Methohexital / Q000378:metabolism; D011247:Pregnancy; D011410:Propanidid / Q000378:metabolism; D011485:Protein Binding; D013874:Thiopental / Q000378:metabolism; D014018:Tissue Distribution
D000777:Anesthetics; D007649:Ketamine; D000530:Alfaxalone Alfadolone Mixture; D011410:Propanidid; D008723:Methohexital; D013874:Thiopental; D004329:Droperidol; D003975:Diazepam; D005283:Fentanyl; D005045:Etomidate